KIF3C has been reported to enhance cancer progress by regulating the phosphatidylinositol 3-kinase (PI3K)/AKT pathway and transforming growth factor beta (TGF-β) pathway [36, 47, 48]. The gene discussed is AKT1; the disease is cancer.